College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China Jiaxing Key Laboratory of Molecular Recognition and Sensing, College of Biological and Chemical Engineering, ...

A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

Akeso and Summit Therapeutics’ giant-killing, PD-1xVEGF bispecific antibody ivonescimab has posted another phase 3 trial win ...

Belfast-based contract research firm Fusion Antibodies has been approved for grant funding to assist it with a project to develop a humanised therapeutic antibody to combat treatment-resistant ...

Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories.

Belgian biotech Argenx has lost its development partner for acute myeloid leukaemia antibody cusatuzumab ... of a deal that had a total value of $1.6 billion. At the time, cusatuzumab was billed ...

Akeso Pharmaceuticals and Summit Therapeutics have reported that their PD-1/VEGF bispecific antibody has met the primary ...